Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06593600
PHASE2

Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

Sponsor: Regeneron Pharmaceuticals

View on ClinicalTrials.gov

Summary

This study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on participants with POTS. The aim of the study is to see how safe, tolerable, and effective the study drug is. The study is looking at several other research questions, including: * How the study drug changes heart rate and blood pressure in participants with POTS * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

Official title: A Phase 2 Double-Blind Placebo-Controlled Single-Dose Study of Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of REGN7544, an NPR1 Antagonist Monoclonal Antibody, in Patients With Postural Orthostatic Tachycardia Syndrome

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

81

Start Date

2024-11-13

Completion Date

2026-06-11

Last Updated

2026-02-10

Healthy Volunteers

No

Interventions

DRUG

REGN7544

Subcutaneous (SC) administration

DRUG

Placebo

SC administration

Locations (18)

Mercy Gilbert Medical Center

Gilbert, Arizona, United States

North County Neurology Associates

Carlsbad, California, United States

Stanford University

Palo Alto, California, United States

Southern California Heart Specialists

Pasadena, California, United States

Yale University

New Haven, Connecticut, United States

Innovative Research of West Florida, Inc.

Clearwater, Florida, United States

Indiana University Health Neuroscience Center

Indianapolis, Indiana, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Mayo Clinic

Rochester, Minnesota, United States

Saint Luke's MidAmerica Heart Institute

Kansas City, Missouri, United States

New York University Langone

New York, New York, United States

Columbia University

New York, New York, United States

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

University of Texas Southwestern

Dallas, Texas, United States

University of Utah

Salt Lake City, Utah, United States

University of Calgary

Calgary, Alberta, Canada

University of Alberta Hospital

Edmonton, Alberta, Canada